Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial, demonstrating the safety, effectiveness and durability of its Coherent Sine-Burst Electroporation (CSE) System for the treatment of paroxysmal and persistent atrial fibrillation (AF). Data presented at AF Symposium 2026 (Boston, Feb. 5–7) showed 94% overall lesion durability, 100% procedural success, and an excellent safety profile using a single, stylet-driven, multi-configurable catheter.

Feb. 9, 2026 — GE HealthCare has announced the United States launch of ReadyFix, a remote fleet management solution designed to help healthcare systems support device uptime. ReadyFix will seamlessly integrate with GE HealthCare’s MAC VU360 resting ECG workstations, which are designed to deliver high-quality ECG readings that help clinicians make faster, more confident cardiac care decisions. When paired with ReadyFix, healthcare systems can leverage real-time** data for remote device diagnosis and repair, supporting optimized MAC VU360 performance and continuity of cardiac care. 

Feb. 9, 2026 — Atraverse Medical presented new clinical and preclinical data at AF Symposium 2026 in Boston, further validating the safety, performance and workflow advantages of the company’s HOTWIRE Transseptal Access System.

Feb. 6, 2026 — Robert Wood Johnson University Hospital (RWJUH), in partnership with Rutgers Robert Wood Johnson Medical School (RWJMS), has earned The Joint Commission’s (TJC) Gold Seal of Approval  as a Comprehensive Cardiac Center (CCC) and the American Heart Association’s (AHA) Heart-Check Mark for Disease-Specific Certification.

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston (Feb. 5-7, 2026) that demonstrate the strong safety and efficacy of the company's minimally invasive therapies to treat people with atrial fibrillation (AFib).

Coronary CT angiography reshapes cath lab planning and patient care.

Advances in coronary CT angiography (CCTA) over the past two decades have helped cardiologists detect heart disease in asymptomatic patients more accurately. Now, providers are using dedicated cardiac CT scanners to plan treatments and improve patient care. Innovations like the Arineta Spotlight Duo bring greater visibility than traditional 64-slice scanners, expanding what’s possible for providers and patients.

Feb. 3, 2026 — The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) organized directly under the umbrella of the European Society of Cardiology (ESC) will take place in Munich, Germany Feb.19 and 20, 2026.

Feb. 3, 2026 — Medtronic plc announced it will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated.

The intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the CathWorks FFRangio System in the U.S., Europe and Japan, where it is commercially available.  

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need in cardiovascular care for patients who, despite currently available therapies, remain at high risk of thromboembolic events, underscoring the need for new innovations to help address one of the leading causes of death in the U.S.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now